Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levetiracetam (Keppra) for levodopa-induced dyskinesias in Parkinson's disease
2005-002208-40Phase 3Completed
- Sponsor
- Sant'Orsola-Malpighi University Hospital
- Start
- Feb 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of levetiracetam in Parkinson's disease (PD) and levodopa-induced dyskinesia (LID), sponsored by Sant'Orsola-Malpighi University Hospital. Started Feb 2006; status: completed.
02
Drugs
levetiracetam
03
Conditions
Parkinson's disease (PD)levodopa-induced dyskinesia (LID)
Beyond the preview
Go deeper on 2005-002208-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002208-40.